Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Q1 interim report January – March 2022

Collections in line with last year whilst earnings were affected by market volatilityHighlights first quarter 2022 · Gross ERC at the end of March 2022 was EUR 296m (297 at December 2021) · Cash at the end of March 2022 was EUR 60.4m (62.7 at December 2021) · Gross collections amounted to EUR 15.7m (14.4)* · Net collections amounted to EUR 12.7m (12.6)* · Cash EBITDA amounted to EUR 11.8m (10.1)* · Net loss for the period of EUR 1.0m (0.2)* including EUR 3.4m mark-to-market loss on the investment in Addiko Bank driven by the proposed CHF law in Slovenia and market

Genetic Analysis AS and Omnigene Medical Technologies Ltd. enter a distribution agreement to launch GA-map[®] in the United Arabic Emirates (UAE) market

OSLO, NORWAY – May 19, 2022: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) hereby announces that GA has entered a distribution and technology transfer agreement with Omnigene Medical Technologies Ltd. (“Omnigene"), a Malta-based biotechnology company, providing advisory services within several therapeutic areas as cancer and neuroscience. In the first stage of the collaboration, Omnigene will launch the GA-map® Dysbiosis Test, a CE-marked standardized gut microbiome test as a service to the UEA market.Gut microbiome profiling is increasingly required in the field of precision

Balder performs share split (6:1) and resolves record date

At the Annual General Meeting of Fastighets AB Balder (publ) (”Balder”) on 12 May 2022, it was decided to divide the company’s shares, whereby each share, regardless of share class, is divided into six (6) new shares (share split 6:1). The Annual General Meeting further resolved to authorize the Board to determine the record date (Sw. avstämningsdag) for the share split. Balder’s Board of Directors has today, with the support of the authorization, resolved that the record date for the share split shall be 27 May 2022. Schedule for the division:24 May 2022: Last day for trading before

Gradientech: Interim report January 1 – March 31, 2022

Gradientech AB (publ) interim report for Q1 2022 is now available on the company's website www.gradientech.se.First quarter January-March 2022 · Net sales amounted to 0 KSEK (0 KSEK). · Net profit amounted to SEK -15,171 KSEK (-9,969 KSEK). · Earnings per share before dilution were SEK -1.04 (SEK -0.82). · Earnings per share after dilution were SEK -0.99 (SEK -0.82). · Cash flow from operating activities amounted to -14,886 KSEK (-14,702 KSEK). · Cash and cash equivalents on the balance sheet date amounted to 74,033 KSEK (55,612 KSEK). · Equity as of March 31 amounted

Financial Report 1st quarter for DOF ASA

The Group's revenue for 1st quarter (management reporting) totals NOK 2,174 million (NOK 1,514 million) and EBITDA totals NOK 767 million (NOK 492 million). The operating profit (EBIT) is NOK 321 million (NOK 45 million), of which depreciation and impairment totals NOK 446 million (NOK 447 million).  Net financial cost amounts to NOK 630 million (NOK -720 million) including unrealised currency gain of NOK 1,010 million (NOK -480 million). The profit is NOK 824 million (NOK -801 million). Key information: Operations · Average utilisation of the fleet in 1[st] quarter was 82% (67%).

Hemsö and Hoivamme develop a nursing home portfolio of EUR 50 million

Hemsö has formed a strategic partnership with the Finnish care operator Hoivamme, which provides elderly care. Hemsö and Hoivamme have signed a framework agreement whereby Hemsö finances the development projects and will become the long-term owner of the properties. Hoivamme will sign 15-year leases for the completed properties.The companies' current agreement involves the construction of 10–12 nursing homes with a total investment of EUR 50 million. The parties have already agreed for four properties which are currently under construction and will be completed during 2022-2023. Hemsö's

Acroud publishes interim report Jan-Mar 2022: Strong organic growth with the right forward momentum

First Quarter 2022 · Revenue amounted to EUR 7 003 (5 579) thousand, corresponding to a growth of 26% (75%) and an organic growth of 15.5% (-9.7%).    · EBITDA amounted to EUR 2 248 (1 441) thousand. Adjusted EBITDA (before items affecting comparability) was EUR 1 781 (1 575) thousand.    · Profit after tax was EUR 1 184 (748) thousand. Adjusted profit after tax (before items affecting comparability and currency effects) was EUR 551 (553) thousand.    · Earnings per share after dilution amounted to EUR 0.009 (0.006). Adjusted earnings per share (before items

Nel ASA: EU Commission increases ambitions on renewable hydrogen

(Oslo, 19 May 2022) Yesterday the European Commission presented a wide range of initiatives to reduce Europe’s reliance on fossil fuels from Russia. A list of proposals aimed to stimulate the production of renewable hydrogen and to improve framework conditions for European electrolyser manufacturers are included in this plan, known as RePowerEU.These proposals include: 1. A call to the co-legislators (European Parliament and the Council) to increase the demand side targets for the use of renewable hydrogen in certain sectors, specifically: · an increase in the industry target from

Intervacc progresses vaccine to prevent mastitis in dairy cows caused by Staphylococcus aureus

Stockholm, May 19, 2022 - Intervacc AB (publ) announces the initiation of a proof-of-concept study to measure the effectiveness of a vaccine to protect dairy cows against mastitis caused by Staphylococcus aureus following successful safety and immunogenicity studies testing this prototype vaccine in pregnant heifers. This next phase of the project will be receiving a grant of 80k Euro from the EU’s VetBioNet initiative. Mastitis is one of the most important diseases of dairy cattle worldwide. Over 2.6 million cases of disease, causing losses of approximately 600M€, occur in European

Cereno Scientific publishes interim report for Q1 2022

The Board and Chief Executive Officer of Cereno Scientific AB here presents the interim report for Q1, 1 January – 31 March, 2022. Summary of the first quarter, January – March 2022Cereno Scientific Group First quarter (1 January – 31 March 2022) · Net Sales were SEK 0 (0) · Result after financial items was SEK -5,246,969 (-3,903,947) · Earnings per share was SEK -0.05 (-0.05) before dilution and SEK -0.04 (-0.03) after dilution · The equity/assets ratio was 93.4% (87.2%) · Cash and bank balance was SEK 77,268,668 (60,071,685) Parent company First quarter (1

ArcticStartup raises funding from celebrity investors like GaryVee

With new startup conferences in new locations and the launch of a new deep tech focused community, ArcticStartup aims to be a leading matchmaker for investors and startups.HELSINKI, Finland (May 19, 2022) ArcticStartup , organizer of Arctic15 , the key matchmaking startup conference in the Nordics and Baltics, has concluded a successful bridge funding round as it resumes physical events for the first time post-pandemic. With the fresh funding, ArcticStartup will take its winning startup event and ecosystem-building concept to the world,

SRV Group Plc: Managers' transactions – Tomi Yli-Kyyny

SRV GROUP PLC       MANAGERS' TRANSACTIONS   19 May 2022     08.50 EEST SRV Group Plc: Managers' transactions – Tomi Yli-Kyyny Notification under the EU Market Abuse Regulation, article 19 SRV Yhtiöt Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Tomi Yli-Kyyny Position: Member of the Board/Deputy member Issuer: SRV Yhtiöt Oyj LEI: 743700GB29FXC0VXF414 Notification type: INITIAL NOTIFICATION Reference number: 15217/4/4 ____________________________________________

SRV Group Plc: Managers' transactions – Heikki Leppänen

SRV GROUP PLC       MANAGERS' TRANSACTIONS   19 May 2022     08.45 EEST SRV Group Plc: Managers' transactions – Heikki Leppänen Notification under the EU Market Abuse Regulation, article 19 SRV Yhtiöt Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Heikki Leppänen Position: Member of the Board/Deputy member Issuer: SRV Yhtiöt Oyj LEI: 743700GB29FXC0VXF414 Notification type: INITIAL NOTIFICATION Reference number: 15213/5/4 ____________________________________________

SRV Group Plc: Managers' transactions – Hannu Leinonen

SRV GROUP PLC       MANAGERS' TRANSACTIONS   19 May 2022     08.40 EEST SRV Group Plc: Managers' transactions – Hannu Leinonen Notification under the EU Market Abuse Regulation, article 19 SRV Yhtiöt Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Hannu Leinonen Position: Member of the Board/Deputy member Issuer: SRV Yhtiöt Oyj LEI: 743700GB29FXC0VXF414 Notification type: INITIAL NOTIFICATION Reference number: 15204/5/4 ____________________________________________

Correction – Everfuel’s first quarter 2022 results

Reference is made to Everfuel A/S’ report of financial information for the first quarter of 2022 published on 19 May 2022.A typographical error has been corrected on page 8 of the report. The report stated that the investments in the first phase of the HySynergy project were “xx million”. In the updated report that has been corrected to “approximately EUR 24 million”. For additional information, please contact: Lea Vindvad Hansen, Investor Relations & Communications Manager, +45 61 83 02 05 About Everfuel | www.everfuel.com Everfuel is making green hydrogen for zero emission

SRV Group Plc: Managers' transactions – Timo Kokkila

SRV GROUP PLC       MANAGERS' TRANSACTIONS   19 May 2022     08.35 EEST SRV Group Plc: Managers' transactions – Timo Kokkila Notification under the EU Market Abuse Regulation, article 19 SRV Yhtiöt Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Timo Kokkila Position: Member of the Board/Deputy member Issuer: SRV Yhtiöt Oyj LEI: 743700GB29FXC0VXF414 Notification type: INITIAL NOTIFICATION Reference number: 15187/4/4 ____________________________________________ Transaction

Change in Anora’s financial calendar for 2022

Anora Group Plc   Stock Exchange Release   19 May 2022 at 8:35 am EET Change in Anora’s financial calendar for 2022   Anora changes the publication date for its January-September 2022 interim report due to changes in the meeting schedule. The new publication date is 23 November 2022 (previously 24 November 2022). Anora applies a silent period of 30 days before the publication of financial reports. ANORA GROUP PLC Contacts: Tua Stenius-Örnhjelm, Investor Relations, tel. +358 40 748 8864 Distribution: Nasdaq Helsinki Ltd Principal media www.anora.com

NCC to construct new emergency hospital in Västerås – planning now initiated

NCC and Region Västmanland are commencing the next step in their cooperation to construct a new emergency hospital in Västerås in partnering form. The parties have now agreed to conduct detailed project planning. The order value is approximately SEK 250 million. Image: Region Västmanland/LINK arkitektur/Carlstetds Arkitekter/TMRW In August, NCC and Region Västmanland agreed to construct a new emergency hospital in Västerås in partnering form. In an initial phase, the parties conducted the preparatory planning. The next project planning phase is now commencing to prepare detailed

SRV Group Plc: Managers' transactions – Heli Iisakka

SRV GROUP PLC       MANAGERS' TRANSACTIONS   19 May 2022     8.30 EEST SRV Group Plc: Managers' transactions – Heli Iisakka Notification under the EU Market Abuse Regulation, article 19 SRV Yhtiöt Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Heli Iisakka Position: Member of the Board/Deputy member Issuer: SRV Yhtiöt Oyj LEI: 743700GB29FXC0VXF414 Notification type: INITIAL NOTIFICATION Reference number: 15171/5/4 ____________________________________________ Transaction

Sivers Photonics partners with Fortune 100 company to deliver next generation laser sources, with initial order worth over $617k

Sivers Semiconductors AB today announced that its subsidiary, Sivers Photonics, has signed a contract worth over $617k to deliver next generation laser sources commencing a partnership agreement with a new customer.The collaboration with the technology business will initially focus on the development and supply of customised lasers across a range of wavelengths, helping enable the customer to develop its future roadmap.Sivers Photonics has extensive experience in designing customised laser chips for a variety of global customers and advanced applications. The new project will utilise this

Checkin.com Group Quarterly Report Q1 2022

Checkin.com Group (STO:CHECK) reports a growth in revenue of 107% during the first quarter of 2022. The report in brief: (Q1 2022 vs Q1 2021): · Net revenue increased to KSEK 15,794 (7,620) which corresponds to a growth of 107 (65)% · Gross profit for the period amounted to KSEK 13,604 (6,561) with a margin of 86 (86)% · EBITDA for the period amounted to KSEK -705 (1,079) with a margin of -4 (14)% · Cash flow from operating activities amounted to KSEK -835 (4,155) · Net Revenue Retention LTM amounted to 140 (130)% · Cash and cash equivalents amounted to KSEK 61,966 (

Anora Q1 22: Solid net sales development in turbulent times

Anora Group Plc   Stock Exchange Release  19 May 2022 at 8:30 am EET Anora Q1 22: Solid net sales development in turbulent times This release is a summary of Anora Group Plc's Interim Report January-March 2022. The complete report is attached to this release and is also available on the company website at: www.anora.com/en/investors  Q1 22 in brief · Net sales were EUR 133.4 million, 0.6% below the Q1 21 pro forma net sales of EUR 134.2 million   · Comparable EBITDA was EUR 13.0 million or 9.8% of net sales (Q1 21 pro forma: EUR 16.7 million or 12.4%) · Net cash flow

SimCorp reports solid order intake, ARR (LTM) growth of 10.4%, revenue growth of 4.3% and EBIT margin of 13.5% in Q1 2022

Company Announcement no.  23/2022Q1 2022 highlights · Total order intake of EUR 26.0m was more than double the EUR 12.6m signed in the same period last year, primarily due to early renewals of two subscription agreements in North America (NA) where revenue will be recognized in Q1 2023 and in 2027, respectively. · In Q1 2022, two new SimCorp Dimension deals in Luxembourg and NA and one new SimCorp Sofia deal in Italy were signed. In addition, we welcomed three new clients through our existing outsourcing partners, and three Investment Accounting Services (IAS) deals were signed. No

SimCorp signs non-binding Memorandum of Understanding with leading investment manager and existing client in APAC

Company announcement no 22/2022SimCorp and a current client and leading investment manager based in APAC have today signed a non-binding Memorandum of Understanding (MOU) setting out the main terms for entering into a strategic business partnership between the parties. The intention being to form a new company to provide a premier, fully integrated, front-to-back investment administration services for asset managers and asset owners in Australia, New Zealand, and Asia. Upon the translation of the MOU into a final strategic agreement, such agreement will become a "large contract" for

There are no items matching the current filter
There are no more items matching the current filter
Back to top